A chemical genetic screen identifies novel ATM/ATR pathway inhibitors that sensitize p53-deficient cells to DNA-damaging agents without affecting ATR kinase catalytic activity

被引：0
|
作者：
Kawasumi, Masaoki [1 ]
Bradner, James E. [2 ]
Tolliday, Nicola [3 ]
Thibodeau, Renee [1 ]
Sloan, Heather [1 ]
Brummond, Kay M. [4 ]
Nghiem, Paul [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 05期
关键词：
D O I：
10.1158/1535-7163.PMS-B04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B04
引用
收藏
页数：1
相关论文
共 6 条
  • [1] A chemical genetic screen reveals novel ATR/ATM pathway inhibitors that sensitize p53-deficient cells to DNA-damaging agents
    Kawasumi, M.
    Sloan, H.
    Bradner, J.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S26 - S26
  • [2] Novel ATM/ATR pathway inhibitors sensitize p53-deficient cells to DNA-damaging agents in vitro and in vivo
    Kawasumi, M.
    Sloan, H.
    Bradner, J.
    Nghiem, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S30 - S30
  • [3] Identification of ATR-Chk1 Pathway Inhibitors That Selectively Target p53-Deficient Cells without Directly Suppressing ATR Catalytic Activity
    Kawasumi, Masaoki
    Bradner, James E.
    Tolliday, Nicola
    Thibodeau, Renee
    Sloan, Heather
    Brummond, Kay M.
    Nghiem, Paul
    CANCER RESEARCH, 2014, 74 (24) : 7534 - 7545
  • [4] Abrogation of the G(2) Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
    Leijen, Suzanne
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03): : 186 - 191
  • [5] Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
    Hirai, Hiroshi
    Iwasawa, Yoshikazu
    Okada, Megumu
    Arai, Tsuyoshi
    Nishibata, Toshihide
    Kobayashi, Makiko
    Kimura, Toshifumi
    Kaneko, Naoki
    Ohtani, Junko
    Yamanaka, Kazunori
    Itadani, Hiraku
    Takahashi-Suzuki, Ikuko
    Fukasawa, Kazuhiro
    Oki, Hiroko
    Nambu, Tadahiro
    Jiang, Jian
    Sakai, Takumi
    Arakawa, Hiroharu
    Sakamoto, Toshihiro
    Sagara, Takeshi
    Yoshizumi, Takashi
    Mizuarai, Shinji
    Kotani, Hidehito
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (11) : 2992 - 3000
  • [6] p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
    Reinhardt, H. Christian
    Aslanian, Aaron S.
    Lees, Jacqueline A.
    Yaffe, Michael B.
    CANCER CELL, 2007, 11 (02) : 175 - 189
1